Abstract
The implementation of screening has greatly contributed to the decrease in incidence and mortality of colorectal cancer (CRC) in many developed countries over the past two decades. Screening from the age of 50 years prevents CRC by enabling the detection and removal of precancerous lesions (advanced adenomatous or serrated polyps) and reduces mortality through early detection (stages I and II) of curable CRC [1].
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
